Scheduled Birth at Term for the Prevention of Pre-eclampsia (PREVENT-PE): An Open-Label Randomized Controlled Trial

( Lancet . 2026;407(10523):67–77. doi: 10.1016/S0140-6736(25)01207-3) Preeclampsia (PEC) is a leading cause of maternal morbidity and mortality worldwide and represents a significant health care burden; an estimated 75% of PEC cases occur at 37 weeks of gestation or greater. The risk for preterm PEC can be identified using the Fetal Medicine Foundation (FMF) competing risks model between 11 and 13 weeks of gestation, and prophylactic treatment with aspirin can prevent more than half of cases with elevated risk. Though assessments and biomarkers can often effectively identify individuals who will develop PEC, there are no proven interventions for preventing PEC that occurs at or near term. One possibility for intervention is planned early term delivery at 39 weeks, which previous literature has shown to reduce the number of cesarean deliveries (CDs) and the rates of other adverse outcomes. This study was designed to assess whether screening at 36 weeks gestation for PEC risk and offering risk-stratified, planned early term delivery would reduce the incidence of PEC.

Authors

Publication Details

Journal
Obstetric Anesthesia Digest
Published
2026-11-18
DOI
https://doi.org/10.1097/01.aoa.0001288936.15779.e4
Primary Topic
Pregnancy and preeclampsia studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Scheduled Birth at Term for the Prevention of Pre-eclampsia (PREVENT-PE): An Open-Label Randomized Controlled Trial

KH Nicolaides, R Akolekar, A Wright, S Webster et al.
4 links
Obstetric Anesthesia Digest
Pregnancy and preeclampsia studies
article

Scheduled Birth at Term for the Prevention of Pre-eclampsia (PREVENT-PE): An Open-Label Randomized Controlled Trial

KH Nicolaides, R Akolekar, A Wright, S Webster, A Syngelaki, J Goadsby, LA Magee, D Wright, P von Dadelszen
article en

Abstract

( Lancet . 2026;407(10523):67–77. doi: 10.1016/S0140-6736(25)01207-3) Preeclampsia (PEC) is a leading cause of maternal morbidity and mortality worldwide and represents a significant health care burden; an estimated 75% of PEC cases occur at 37 weeks of gestation or greater. The risk for preterm PEC can be identified using the Fetal Medicine Foundation (FMF) competing risks model between 11 and 13 weeks of gestation, and prophylactic treatment with aspirin can prevent more than half of cases with elevated risk. Though assessments and biomarkers can often effectively identify individuals who will develop PEC, there are no proven interventions for preventing PEC that occurs at or near term. One possibility for intervention is planned early term delivery at 39 weeks, which previous literature has shown to reduce the number of cesarean deliveries (CDs) and the rates of other adverse outcomes. This study was designed to assess whether screening at 36 weeks gestation for PEC risk and offering risk-stratified, planned early term delivery would reduce the incidence of PEC.

Obstetric Anesthesia DigestVol. 46(4)
Good health and well-being
Pregnancy and preeclampsia studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon